相关实验视频

Updated: Jun 15, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

聚菲林VII作为一种潜在的药物,用于向甲状腺癌中的上皮介质介质过渡蛋白

Qingqing Yu¹, Jinglin Chen², Chen Zhong³

¹Biomedical Research Institute, Hubei University of Medicine, Shiyan City, Hubei Province, PR China.

Journal of pharmacological sciences

|August 23, 2024

概括

聚林VII (PPVII) 通过抑制细胞增殖和转移,显示出作为抗甲状腺癌 (TC) 药物的前景. 它有效地针对TC细胞中的上皮-介质酶转换 (EMT),提供了潜在的新疗法策略.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

甲状腺癌 (TC) 发病率和转移率正在上升,需要新的治疗药物.
目前对高级TC的治疗方法有限,这凸显了迫切需要开发新的药物.
表皮-介质细胞过渡 (EMT) 是癌症转移的一个关键过程.

研究的目的:

为了研究多林VII (PPVII) 对甲状腺癌细胞的抗癌作用.
探索PPVII行动的潜在机制,特别是它对EMT的影响.
评估PPVII作为治疗药物在TC中准EMT的潜力.

主要方法:

利用B-CPAP和TPC-1细胞系来评估PPVII的抗瘤活性.
量化了与EMT相关的基因的细胞增殖,迁移和表达 (E-cadherin,Vimentin,N-cadherin,Slug,Zeb-1,Foxe1).
分析生物信息数据库,以研究与TC和临床阶段相关的Foxe1基因表达.

主要成果:

根据剂量,PPVII显著降低了TC细胞的增殖和迁移.
PPVII治疗增加了E-cadherin的表达,同时降低了Vimentin,N-cadherin,Slug,Zeb-1和Fox1的表达.
福克斯1基因表达与TC进展和EMT有关,PPVII抑制了TC细胞中的福克斯1表达.

结论:

PPVII通过抑制细胞生长和转移,显示出强大的抗甲状腺癌活性.
在甲状腺癌中,PPVII可能通过抑制上皮层-介质细胞过渡 (EMT) 来发挥其作用.
在甲状腺癌治疗中,PPVII显示出作为一种针对EMT的新疗法药物的潜力.

关键词:

在EMT中,EMT是EMT.福克斯 (Fox) 是一个人.在PPVII中,PPVII是PPVII,PPVII是PPVII 甲状腺癌是什么?甲状腺癌是什么?

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cadherins in Tissue Organization

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...